Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target.

Published

Journal Article

The NKX2-1 transcription factor, a regulator of normal lung development, is the most significantly amplified gene in human lung adenocarcinoma. To study the transcriptional impact of NKX2-1 amplification, we generated an expression signature associated with NKX2-1 amplification in human lung adenocarcinoma and analyzed DNA-binding sites of NKX2-1 by genome-wide chromatin immunoprecipitation. Integration of these expression and cistromic analyses identified LMO3, itself encoding a transcription regulator, as a candidate direct transcriptional target of NKX2-1. Further cistromic and overexpression analyses indicated that NKX2-1 can cooperate with the forkhead box transcription factor FOXA1 to regulate LMO3 gene expression. RNAi analysis of NKX2-1-amplified cells compared with nonamplified cells demonstrated that LMO3 mediates cell survival downstream from NKX2-1. Our findings provide new insight into the transcriptional regulatory network of NKX2-1 and suggest that LMO3 is a transcriptional signal transducer in NKX2-1-amplified lung adenocarcinomas.

Full Text

Duke Authors

Cited Authors

  • Watanabe, H; Francis, JM; Woo, MS; Etemad, B; Lin, W; Fries, DF; Peng, S; Snyder, EL; Tata, PR; Izzo, F; Schinzel, AC; Cho, J; Hammerman, PS; Verhaak, RG; Hahn, WC; Rajagopal, J; Jacks, T; Meyerson, M

Published Date

  • January 15, 2013

Published In

Volume / Issue

  • 27 / 2

Start / End Page

  • 197 - 210

PubMed ID

  • 23322301

Pubmed Central ID

  • 23322301

Electronic International Standard Serial Number (EISSN)

  • 1549-5477

Digital Object Identifier (DOI)

  • 10.1101/gad.203208.112

Language

  • eng

Conference Location

  • United States